Both in Pharmaceuticals
Elanco Animal Health Incorporated vs BridgeBio Pharma
Over the past year ELAN returned +4.1% and BBIO returned +19.7%; their daily moves had a correlation of 0.15.
ELAN +4.1% BBIO +19.7%Growth of $1, one year, split-adjusted
| Metric | ELAN | BBIO |
|---|---|---|
| Price | $23.06 | $74.95 |
| Market cap | $11.52B | $14.60B |
| Today | −0.77% | +5.97% |
| 1 month | +5.9% | +12.0% |
| 6 months | +2.4% | +9.3% |
| Year to date | +1.9% | −2.0% |
| 1 year | +2.1% | +12.5% |
| Revenue growth (YoY) | +10.2% | +192.6% |
| Gross margin | 58.3% | 94.2% |
| Net margin | 3.9% | −23.5% |
| P/E (TTM) | — | — |
| Price / sales | 2.3× | 15.4× |
| Net cash | -$3.39B | -$938.6M |
| Dividend yield | — | — |
| Volatility (60d) | 34.2% | 32.7% |
| Short % of float | 6.3% | 12.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).